HOME PAGE

References:
Alzheimer / MCI
  • Catherine C. Price et al. Clock Drawing in the Montreal Cognitive Assessment: Recommendations for Dementia
    Assessment. Dementia and Geriatric Cognitive Disorders 2011;31:179-187.
  • H. Chertkow, N. Phillips, Z. Nasreddine, V. Whitehead. Severity of mild cognitive impairment does not predict
    progression. Presented at the ADI Toronto, March 29, 2011.
  • Anne M. Damian et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores. Dementia and Geriatric Cognitive Disorders, 2011;31:126-131.
  • Thissen AJ et al. Applicability and validity of the Dutch version of the Montreal Cognitive Assessment (MoCA-d) in diagnosing MCI.Gerontol Geriatr 2010 Dec;41(6):231-40.
  • Cuttini C. et al. Initiation in Dementia: Are we detecting it? Department of Medicine, division of Geriatrics, Queen's University,Kingston, Ontario, Canada. Abstract presented at the Canadian Conference on Dementia, Toronto, Oct. 1-3, 2010.
  • Michael Lerch et al. Could the Montreal Cognitive Assessment (MoCA) be the new "gold standard" in cognitive evaluation in geriatric patients: a clinical comparison. The Journal of the Alzheimer's Association, Vol. 6, Issue 4, Supplement page S494, July 2010.
  • Kaynak Selekler et al. Power of discrimination of Montreal Cognitive Assessment (MoCA) Scale in Turkish Patients with Mild Cognitive Impairment and Alzheimer's Disease. Turkish Journal of Geriatrics 2010;13(3) 166-171.
  • Fujiwara Y. et al. Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the  Montreal Cognitive Assessment. Geriatr Gerontol. Int. 2010;10:225-232.
  • Guo Qi-Hao et al. Application study of quick cognitive screening test in identifying mild cognitive impairment. Neuroscience Bulletin, February 2010, 26(1):47:54.
  • Walter Wittich, Natalie Phillips, Ziad Nasreddine, Howard Chertkow. Sensitivity and specificity of the Montreal Cognitive Assessment modified for individuals who are visually impaired. Journal of Visual Impairment & Blindness, June 2010, 104(6), 360-368.
  • Luis CA et al. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry, Online issue, October 21st, 2008, published 2009;24: 197-201.
  • Ging-Yuek R. Hsiung et al. A Pilot Study on Computerized Cognitive Training in Mild Cognitive Impairment. 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 124.
  • A. Garcia et al. Apathy in Dementia: Are we detecting it? 5th Canadian Conference on Dementia in Toronto,
    Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 121.
  • Lisa Sweet, phd et al. The Montreal Cognitive Assessment (MoCA) in Geriatric Rehabilitation: Psychometric Properties and Association with Rehabilitation Outcomes. 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 113.
  • Benjamin Lam et al. Validation of the Montreal Cognitive Assessment against Detailed Neuropsychological Measures. 5th Canadian Conference on Dementia in Toronto, Oct. 1-3, 2009. The Canadian Journal of Geriatrics, Volume 12, Issue 3, Sept. 2009, page 138.
  • Hemrungrojn S et al. The cognitive domains from Thai-Montreal cognitive assessment test to discriminate between amnestic MCI and mild AD from normal aging. Presented at the International Psychogeriatric Association Conference, Sept. 2009, Montreal, Quebec, Canada.
  • Koski L. et al. Measuring Cognition in a Geriatric Outpatient Clinic: Rasch Analysis of the Montreal Cognitive Assessment. Journal of Geriatric Psychiatry and Neurology, Volume 22, Number 3, Sept. 2009, page 151-160.
  • Rahman, Tomader Taha Abdel; El Gaafary, Maha Mohamed. Montreal Cognitive Assessment Arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatrics and Gerontology International, Volume 9, Number 1, March 2009, pp. 54-61 (8).
  • JL Richard et al. Use of the MoCA in Patients Presenting to a Memory Disorders Clinic. Am J Geriatr Psychiatry 2009; 17:A112.
  • Jun-Young Lee et al. Brief Screening for Mild Cognitive Impairment in Elderly Outpatient Clinic: Validation of the Korean Version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol, June 2008, 21;2:104-110.
  • Nestor SM et al. The Montreal Cognitive Assessment: a retrospective pilot study measuring longitudinal cognitive change in people with mild cognitive impairment. Presented at the Annual Meeting of the Canadian Geriatrics Society, Montreal, Canada. Canadian J of Geriatrics, Volume 11, Issue 1, March 2008, p63.
  • Smith M et al. Case finding of people with cognitive impairment using screening clinics during Alzheimer awareness month. Presented at the Annual Meeting of the Canadian Geriatrics Society, Montreal, Canada. Canadian J of Geriatrics, Volume 11, Issue 1, March 2008, p37.
  • Tobinick et al. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. Journal of Neuroinflammation, January 2008, 5:2 (e-publication).
  • Rolf Sebaldt et al. Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: The Decide Study, The Canadian Journal of Neurological Sciences, Volume 36, Issue 5, Sept. 2009, page 599.
  • Song S et al. Executive impairment and MoCA performance in mild cognitive impairment and Alzheimer's disease. Presented at the International Neuropsychological Society Annual Meeting. Buenos Aires, Argentina. July 2-5, 2008, p. 258.
  • Wen HB et al. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Zhonghua Nei Ke Za Zhi. 2008 Jan;47(1):36-9. Chinese.
  • Shiroky et al. Can you have dementia with an MMSE score of 30. Am J of Alzheimers Dis Other Demen Oct-Nov 2007;22:5;406-415.
  • Smith T et al. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry, 2007 May; 52(5):329-32.
  • J. Reban. Montrealsky kognitivni test/MoCA/: prinos k diagnostice predemenci, Ceska Geriatricka, Revue 2006 (4):224-229.
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H.
    The Montreal Cognitive Assessment (MoCA): A Brief Screening Tool For Mild Cognitive Impairment.
    Journal of the American Geriatrics Society 53:695-699, 2005.
  • Nasreddine ZS et al. The Montreal Cognitive Assessment (MoCA): a Brief Cognitive Screening Tool for
    Detection of Mild Cognitive Impairment. Neurology, Volume 62, Number 7 S(5) April 2004, A132. Presented at the American Academy of Neurology Meeting, San Francisco, May 2004.
  • Nasreddine ZS et al. The Montreal Cognitive Assessment (MoCA): a Brief Cognitive Screening Tool for Detection of Mild Cognitive Iimpairment. Presented at the 8th International Montreal/Springfield Symposium on Advances in Alzheimer Therapy. http://www.siumed.edu/cme/AlzBrochure04.pdf, p.90, April 14-17, 2004.
  • Nasreddine ZS et al. Sensitivity and Specificity of The Montreal Cognitive Assessment (MoCA) for Detection of Mild Cognitive Deficits. Can J Neurol Sci., Volume 30, Number 2, Supplement 2/May 2003, p.30. Presented at Canadian Congress of Neurological Sciences Meeting, Quebec City, Quebec, June 2003.
HIV
  • Chartier, M. et al. The Montreal Cognitive Assessment (MoCA): A pilot study of a brief screening tool for mild and moderate cognitive impairment in HIV-positive Veterans. Poster presentation at the American Conference for the Treatment of HIV. (2011, April).
  • Meera Oza. Brain injury and lower cognitive function are common in people with HIV (CROI 2011). The AIDS Beacon.
  • Koski L. et al. Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment. HIV Med. 2011 Mar 13. doi: 10.1111/j.1468-1293.2010.00910.x. (Epub ahead of print). 
    Huntington
  • Videnovic A. et al. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Movement Disorders, 2010: 25(3):401-4.
  • Mickes Laura et al. A Comparison of Two Brief Screening Measures of Cognitive Impairment in Huntington's Disease. Movement Disorders, Volume 25, Issue 13, pages 2229-2233, Oct. 2010.
  • Lessig S. et al. Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease. Poster. Neurotherapeutics, Volume 7, Number 1, 2010, page 139.
Huntington
  • Videnovic A. et al. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Movement Disorders, 2010: 25(3):401-4.
  • Mickes Laura et al. A Comparison of Two Brief Screening Measures of Cognitive Impairment in Huntington's Disease. Movement Disorders, Volume 25, Issue 13, pages 2229-2233, Oct. 2010.
  • Lessig S. et al. Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease. Poster. Neurotherapeutics, Volume 7, Number 1, 2010, page 139.
Multiple Sclerosis
  • Lauren Krupp et al. The Montreal Cognitive Assessment (MoCA) as a Screening Tool for Cognitive Functioning in Multiple Sclérosis (MS). Neurology, Volume 76, Number 9, March 1, 2011. Abstract P06.082.
  • K. Waspe et al. Evaluation of Modified Montreal Cognitive assessment in multiple sclerosis: a pilot study. Multiple Sclerosis, 2008;14(supp 1) p. S29. Presented at ECTRIMS meeting, Montreal, Sept. 2008.
Parkinson
  • Roser Ribosa et al. Comparative Accuracy of the PD-CRS, Mattis DRS, MoCA and SCOPA-COG for Screening Mild Cognitive Impairment in Parkinson's Disease. Neurology, Volume 76, Number 9, March 1, 2011. Abstract P06.088.
  •  Melissa J. et al. Validating the Montreal Cognitive Assessment for the Diagnosis of Mild Cognitive Impairment in Parkinson's Disease. Neurology, Volume 76, Number 9, March 1, 2011. Abstract P07.084.
  • J.C. Dalrymple-Alford et al. The MoCA: Well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010;75;1717.
  • Hanna-Pladdy B. et al. Utility of the NeuroTrax computerized Battery for Cognitive Screening in Parkinson's Disease: Comparison with the MMSE and the MoCA. International Journal of Neuroscience, August 2010;120(8):538-43.
  • Meike Kasten et al. Validity of the MoCA and MMSE in the detection of MCI and Dementia in Parkinson's disease. Neurology 2010 75;479-479.
  • Sarah H. et al. Pilot study of a three-step diagnostic pathway for young and old patients with Parkinson's disease dementia: screen, test and then diagnose. International Journal of Geriatric Psychiatry 2010;25:258-265.
  • Luo Xia-Guang et al. Cognitive Deterioration Rates in Patients with Parkinson's Disease from Northeastern China. Dementia and Geriatric Cognitive Disorders 2010;30:64-70.
  • Melzer T R et al. Cognition and the limbic system in early Parkinson's disease: A DTI investigation. Abstract, NeuroImage 2009, 47 (Suppl. 1): S115.
  • Hoops S et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009, November 24; 73(21):1738-1745.
  • Sarra et al. Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with "Normal" Global Cognition According to Mini-Mental State Examination Score. J Am Geriatr Soc, Volume 57, Number 2, February 2009, pp. 304-308(5).
  • Gill DJ et al. The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disorders, Volume 23, Number 7, 2008, pp. 1043-1046.
  • Lessig S et al. Examination of the Montreal Cognitive Assessment (MoCA) and MMSE in Parkinson's disease (PD). Abstract T-82. Presented at American Neurological Association Meeting, Salt Lake City, Utah, Sept. 24th, 2008.
  • Zadikoff C et al. A comparison of the Mini-Mental state exam to the Montreal Cognitive Assessment in identifying cognitive deficits in Parkinson's disease. Mov Disorders, 2008 January 30;23(2):297-9.
REM
  • Gagnon JF. et al. The Montreal Cognitive Assessment: A Screening Tool for Mild Cognitive Impairment in REM Sleep Behavior  Disorder. Movement Disorders 2010, May 15;25(7):936-40.
 Stroke rehabilitation
  • Aggarwal A, Kean E. Comparison of the Folstein Mini Mental State Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) as a Cognitive Screening Tool in an Inpatient Rehabilitation Setting. Neuroscience & Medicine, 2010, 1, 39-42.
Substance disorders
  • Copersino ML et al. Rapid cognitive screening of patients with substance abuse disorders. Experimental and Clinical Psychopharmacology 17(5):337-344, 2009.
Tumors
  • Olson R et al. Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases. Support Care Cancer, published online October 19th, 2010.
  • Olson R et al. Investigation of cognitive screening measures in patients with brain tumors: diagnostic accuracy & correlation with quality of life. 2009 American Society of Clinical Oncology Annual Meeting. Orlando, Florida. May 29-June 2, 2009. Abstract ID:e13000.
  • Olson R et al. Comparison of the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (M0CA) to a Comprehensive Neuropsychological Assessment in Patients with Brain Tumors. 11 th World Congress of Psycho-Oncology. Vienna, Austria. June 21-25, 2009. Abstract P3.7.17.
  • Olson R et al. Comparison of Two Cognitive Screening Measures, the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), in Patients with Brain Tumors. Canadian Association of Psychosocial Oncology, 2009 Conference. Vancouver, British Columbia. April 1-4, 2009. Abstract ID:P245.
  • Olson RA et al. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Supportive Care  in Cancer. March 12, 2008, 16:1273-1278.
Vascular
  • Olivier Godefroy et al. Is the Montreal Cognitive Assessment Superior to the Mini-Mental State Examination to detect Poststroke Cognitive Impairment?: A Study with neuropsychological evaluation. Stroke 2011;42:00-00. Published online Apr 7, 2011.
  • Martinic Popovic, A. Lovrencic-Huzjan, A. M. Simundic, V. Demarin. Mild cognitive impairment in patients with carotid disease. Presented at the ADI Toronto, March 29, 2011. 
  • Harkness K et al. Screening for Cognitive Deficits Using the Montreal Cognitive Assessment Tool in Outpatients ≥65 Years of Age With Heart Failure. Am J. Cardiol. 2011, Feb 9. Abstract.
  • S. N. McLennan et al. Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population. Journal of Geriatric Psychiatry and Neurology. Online publication December 14, 2010.
  • Ira H. Bernstein et al. Psychometric Evaluation of the Montreal Cognitive Assessment (MoCA) in Three
    Diverse Samples. The Clinical Neuropsychologist 2010, 1-8, iFirst.
  • Cameron J. et al. Does cognitive impairment predict poor self-care in patients with heart failure?
    European Journal of Health failure 2010, 12, 508-515.
  • Pendlebury S.T. et al. Underestimation of Cognitive Impairment by Mini-Mental State Examination Versus
    the Montreal Cognitive Assessment in Patients with Transient Ischemic Attack and Stroke. A Population-Based Study. Stroke Journal of the American Heart Association, 41(6):1290-1293, June 2010.
  • Dong Y et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci (2010), doi:10.1016/j.jns.2010.08.051.
  • Pendlebury S et al. Impairment on Montreal Cognitive Assessment in transient ischaemic attack and stroke patients with normal Mini-Mental State Examination score is clinically relevant. Journal Neurol Neurosurg. Psychiatry 2010 81:e68 Abstract.
  • McLennan SN et al. Cognitive Impairment Predicts Functional Capacity in Dementia-Free Patients With Cardiovascular Disease. J Cardiovasc Nurs. 2010 September/October;25(5):390-397 Abstract.
  • Wong A. et al. The Validity, Reliability and Clinical Utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in Patients with Cerebral Small Vessel Disease, Dement Geriatr Cognitive Disorders, August 2009;28:81-87.
  • Rolf Sebaldt et al. Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: The Decide Study, The Canadian Journal of Neurological Sciences, Volume 36, Issue 5, Sept. 2009, page 599.
  • Wong A et al. The Validity, Reliability and Utility of the Cantonese Montreal Cognitive Assessment (MoCA) in Chinese Patients with Confluent White Matter Lesions. Hong Kong Med J, Volume 14, Number 6, Supplement 6, December 2008.
  • Boulanger JM et al. A prospective cognitive evaluation in post stroke/TIA patients using the Montreal Cognitive Assessment test (MoCA). Presented at Nice, France. European Stroke Conference, May 2008.
  • Ponrathi Athilingam. The Montreal Cognitive Assessment (MoCA): An appropriate tool to assess subtle cognitive changes in people with heart failure? Section: "Innovations in Nursing Practice with Older Adults". Presented at the ENRS 20th scientific conference. Philadelphia, March 27th, 2008.
  • Martinic Popovic I. et al. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. Journal of the Neurological Sciences, Volume 257, Issues 1-2, 15 June 2007, pages 185-193.
  • J Malcolm O Arnold et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or actue decompensation, and use of biomarkers. Can J Cardiol, Volume 23, Number 1, January 2007.
  • Martinic-Popovic I. et al. Early detection of mild cognitive impairment in patients with cerebrovascular disease. Acta Clin Croat 2006; 45:77-85.
  • Hachinski et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006, Sept.:37(9):2220-41.
Visual Impairment
  • Walter Wittich, Natalie Phillips, Ziad Nasreddine, Howard Chertkow. Sensitivity and specificity of the Montreal Cognitive Assessment modified for individuals who are visually impaired. Journal of Visual Impairment & Blindness, June 2010, 104(6), 360-368.
Other
  • Irak-Dersu I et al. Effect of dilating drops on cognitive function. Presented at 35th annual North American Neuro-ophthalmology meeting, February 24, 2009, Lake Tahoe, Nevada.
  • Irak-Dersu I et al. The Effect of Mydriatic Eye Drops on Cognitive Function in Claucoma Patients. Presented at 19th annual American Glaucoma Society meeting, March 6, 2009, San Diego, CA.
NORMATIVE DATA
Low education:
  • Johns, EK et al. The effect of education on performance on the Montreal Cognitive Assessment (MoCA):
    Normative data from the community. The Canadian Journal of Geriatrics, 11, 32-73. (Poster presented at the 28th annual meeting of the Canadian Geriatrics Society, Montreal, Quebec, April 2008.
  • Johns, EK et al. The Montreal Cognitive Assessment: Normative data in the community. Journal of the International Neuropsychological Society, 14 (Suppl.1), i-292. (Poster presented at the 36th annual meeting of the International Neuropsychological Society, Waikoloa, Hawaii, February 2008).
Young adults:
  • Ratchford TL et al. Normative Data for the Montreal Cognitive Assessment (MoCA) in Young Adults. P05.128. Presented at the American Academy of Neurology Meeting. April 2008. Neurology 70, March 11, 2008 (Suppl 1) A283.
REVIEWS
  • Zahinoor Ismail et al. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010;25: 111-120.
  • Bredje A. Appels, MSc and Erick Scherder, Phd. the Diagnostic Accuracy of Dementia-Screening Instruments With an Administration Time of 10 to 45 Minutes for Use in Secondary Care: A Systematic Review. American Journal of Alzheimer's Disease & Other Dementias 2010, 25(4) 301-316.
  • Manuel Montero-Odasso, Susan W. Muir. Simplifying detection of mild cognitive impairment subtypes. Journal of the American Geriatrics Society, May 2010-Vol.58, no. 5.
  • Guo Qi-Hao et al. Application study of quick cognitive screening test in identifying mild cognitive impairment. Neuroscience Bulletin, February 2010, 26(1):47:54.
  • Lonie Jane A. et al. Screening for mild cognitive impairment: a systematic review. International Journal of Geriatric Psychiatry 2009; 24: 902-915.
  • Shiroky et al. Can you have dementia with an MMSE score of 30. Am J of Alzheimers Dis & Other Demen, Oct.-Nov. 2007;22:5; 406-415.
  • Chertkow H, Nasreddine Z, et al. Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis Alzheimer's & Dementia: The Journal of the Alzheimer's Association October 2007 (Vol. 3, Issue 4, pages 266-282).
  • Howe E. Initial screening of patients for Alzheimer's disease and minimal cognitive impairment. Psychiatry, Volume 4 (7), July 2007, 24-27.
  • Gauthier et al. Mild cognitive impairment. Lancet. 2006 April 15;367(9518):1262-70, Review.
  • Hachinski et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006, Sept.;37(9):2220-41.
  • Allan L et al. Mild Cognitive Impairment: An Opportunity to Identify Patients at High Risk for Progression to Alzheimer's Disease. Clin Ther 2006;28:991-1001.
  • Olson R., Parkinson M., McKenzie M. Selection Bias Introduced by Neuropsychological Assessments. Canadian Journal of Neurological Sciences, 2010;37:264-268.
LANGUAGE VALIDATION
Arabic:
  • Rahman et al. Montreal Cognitive Assessment Arabic version: Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatrics and Gerontology International, Vol. 9, number 1, March 2009, pp. 54-61 (8).
Chinese (Beijing):
  • Wen HB et al. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Zhonghua Nei Ke Za Zhi. 2008. Jan;47(1):36-9. Chinese.
Chinese (Hong Kong):
  • Adrian Wong et al. The Validity, Reliability and Clinical Utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in  patients with cerebral small vessel disease, Dement Geriatr Cogn Disord, Aug. 2009;28-81-87.
  • Wong A et al. The Validity, Reliability and Utility of the Cantonese Montreal Cognitive Assessment (MoCA) in Chinese Patients with Confluent White Matter Lesions. Hong Kong Med J, Volume 14, Number 6, Supplement 6, December 2008.
 Czech:
  • J.Reban. Montrealsky kognitivni test/MoCA/: prinos k diagnostice predemenci, Ceska Geriatricka Revue 2006 (4): 224-229.
Croatian:
  • Martinic-Popovic I. et al. Early detection of mild cognitive impairment in patients with cerebrovascular disease.
    Acta Clin Croat 2006;45-77-85.
Dutch:
  • Thissen AJ et al. Applicability and validity of the Dutch version of the Montreal Cognitive Assessment
    (MoCA-d) in diagnosing MCI. Gerontol Geriatr. 2010 Dec;41(6):231-40.
  • Janneke Thissen et al. Validity of the Montreal Cognitive Assessment Dutch Version (MoCA-D), presented at the international Psychogeriatric Association Conference, Sept. 2009, Montreal, Quebec, Canada.
French:
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment (MoCA): A brief screening tool for mild cognitive impairment. J Am Geriatr. Soc. 53:695-699, 2005.
English:
  • Luis CA et al. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults
    residing in the Southeastern US. International Journal of Geriatric Psychiatry, Online issue, October 21st, 2008, published 2009;24: 197-201.
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment (MoCA): A brief screening tool for mild cognitive impairment. J Am Geriatr. Soc. 53:695-699, 2005.
Japanese:
  • Fujiwara Y. et al. Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int. 2010;10:225-232.
Korean:
  • Jun-Young Lee et al. Brief Screening for Mild Cognitive Impairment in Elderly Outpatient Clinic: Validation of the Korean Version of Montreal Cognitive Assessment 2008; J Geriatr Psychiatry Neurol, June 2008, 21;2:104-110.
Polish:
  • Joanna Magierska, Radoslaw Magierski, Tomasz Sobow, Iwona Kloszewska. The Polish adaptation of the Montreal Cognitive Assessment (MoCA) and preliminary results of its clinical utility in the screening for cognitive impairment. Presented at ICAD Conference Poster 2008, Chicago.
Portuguese (Brazil):
  • Bertolucci PH et al. Brazilian Portuguese version for the Montreal Cognitive Assessment (MoCA) and the preliminary results. Presented at Alzheimer's Association International Conference on Alzheimer's Disease. Alzheimer's and Dementia, Volume 4, Issue 4, Supplement 1, July 2008, Page T686.
  • Bertolucci PH et al. Brazilian Portuguese version for the Montreal Cognitive Assessment (MoCA) and
    the preliminary results. Presented at Alzheimer's Association International Conference on Alzheimer's
    Disease. Alzheimer's and Dementia, Vol. 4, Issue 4 Supplement 1, July 2008, page T686.
Thai:
  • Tangwongchai S et al. The Validity of Thai version of the Montreal Cognitive Assessment (MoCA-T), Presented at the International Psychogeriatric Association Conference, Sept. 2009, Montreal, Quebec, Canada.
Turkish:
  • Selekler K. & Cangoz B. (October 2009). Predictive Validity Study of MoCA on Turkish Patients with MCI and Alzheimer Dementia. (Poster). 19th World Congress of Neurology (WCN 2009), Bangkok, Thailand.
  • Kaynak Selekler et al. Power of discrimination of Montreal Cognitive Assessment (MoCA) Scale in Turkish Patients with Mild Cognitive Impairment and Alzheimer's Disease. Turkish Journal of Geriatrics 2010;13(3) 166-171.
Return to HOME PAGE

Copyright© Dr Z. Nasreddine 2003 to 2012 - The Montreal Cognitive Assessment - MoCA© - All rights reserved